Literature DB >> 32247265

Follistatin like protein-1 modulates macrophage polarization and aggravates dextran sodium sulfate-induced colitis.

Guanwei Li1, Huajian Ren2, Xiuwen Wu2, Qiongyuan Hu2, Zhiwu Hong2, Gefei Wang2, Guosheng Gu2, Jianan Ren3, Jieshou Li2.   

Abstract

Follistatin-like protein 1 (FSTL1) is a pleiotropic cytokine involved in multiple processes including organ development, carcinogenesis, metastasis and so on. Some recent studies have suggested a possible role of FSTL1 in the inflammatory diseases. We for the first time tried to unravel its effect on the colitis, and explore the possible mechanisms. Here we found that FSTL1 was upregulated in active human and murine colitis. It facilitated proinflammatory M1 polarization of macrophages and inhibited the M2 anti-inflammatory phenotype, leading to excessive production of multiple inflammatory cytokines in vitro and in vivo. Haplodeletion of FSTL1 in mice significantly reduced the clinical and histological activity of colitis. Most importantly, macrophage depletion diminished the difference between DSS-treated WT and FSTL1+/- mice. Altogether, our results suggested that FSTL1 may also serve as an important contributor in the colonic inflammation. The possible mechanism may be related to its modulation on macrophage polarization.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colitis; Follistatin like protein-1; Macrophage polarization

Mesh:

Substances:

Year:  2020        PMID: 32247265     DOI: 10.1016/j.intimp.2020.106456

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  1 in total

1.  Association between follistatin-related protein 1 and the functional status of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Taejun Yoon; Sung Soo Ahn; Jung Yoon Pyo; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Chin Med J (Engl)       Date:  2021-04-14       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.